Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: A clinicopathologic study

Liver International

Volumn 26, Issue 7, 2006, Pages 817-826

  Tsamandas, Athanassios C ^a   Syrokosta, Ioulia ^a   Thomopoulos, Konstantinos ^a   Zolota, Vassiliki ^a   Dimitropoulou, Dimitra ^a   Liava, Anna ^a   Coupoulou, Anna Antona ^a   Siagris, Dimitrios ^a   Petsas, Theodore ^a   Karatza, Chrisoula ^a   Gogos, Charalambos A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Chronic hepatitis C; Fibrosis; Hepatic progenitor cells; Therapy

Indexed keywords

ALPHA FETOPROTEIN; AMINOTRANSFERASE; ANTIVIRUS AGENT; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; INTERFERON; MESSENGER RNA; PARAFFIN; PEGINTERFERON ALPHA2B; PROTEIN ANTIBODY; RIBAVIRIN;

ADULT; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NONHUMAN; PATHOLOGY; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STEM CELL;

ADULT; ALPHA-FETOPROTEINS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; KERATIN-19; KERATIN-7; LIVER; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; STEM CELLS;

EID: 33746762849     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01306.x     Document Type: Article

References (39)

1. Leone N, Rizzetto M. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 2005; 51 (1): 31-46.
2. Hughes C A, Shafran S D. Chronic hepatitis C virus management: 2000-2005 update. Ann Pharmacother 2006; 40 (1): 74-82.
3. Lemire J M, Shiojiri N, Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol 1991; 139: 535-52.
4. Evarts R P, Nagy P, Marsden E, Thorgeirsson S S. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987; 8: 1737-40.
5. Hixson D C, Fowler L C. Development and phenotypic heterogeneity of intrahepatic biliary epithelial cells. In: Sirica A E, Longnecker D S, eds. Biliary and Pancreatic Ductal Epithelia: Pathobiology and Pathophysiology. New York: Marcel Dekker, 1997; 1-40.
6. Roskams T A, Theise N D, Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: Canalas of herring, ductules and ductular reactions in human livers. Hepatology 2004; 39: 1739-45.
7. Evarts R P, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson S S. In vivo differentiation of rat oval cell hepatocytes. Cancer Res 1989; 49: 1541-7.
8. Petersen B E, Zajac V F, Michalopoulos G K. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 1998; 27: 1030-8.
9. Felekouras E S, Tsamandas A C, Tepetes K, et al. Oval cell activation in response to injury following different models of hepatic damage with or without inhibition of mature hepatocytes proliferation [abstract]. Mod Pathol 2000; 13: 183A.
10. Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res 1956; 16: 142-8.
11. Germain L, Noel M, Gourdeau H, Marceau N. Promotion of growth and differentiation of rat ductular oval cells in primary culture. Cancer Res 1988; 48: 368-78.
12. Shiojiri N, Lemire J M, Fausto N. Cell lineage and oval cell progenitors in rat liver development. Cancer Res 1991; 51: 2611-20.
13. Dabeva M D, Shafritz D A. Activation, proliferation and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of the liver regeneration. Am J Pathol 1993; 143: 1606-20.
14. Fausto N. Liver stem cells. In: Arias I M, Boyer J L, Fausto N, Jacoby W B, Schachter D A, Shafritz D A, eds. The Liver: Biology and Pathobiology, 3rd edn. New York: Raven, 1994; 1501-18.
15. Faris R A, Monfils B A, Dunsford H A, Hixson D C. Antigenic relationship between oval cells and subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte"model system. Cancer Res 1991; 51: 1308-17.
16. Thorgeirsson S S, Evarts R P, Bisgaard H C, Fujio K, Hu Z. Hepatic stem cell compartment: Activation and lineage commitment. Proc Soc Exp Biol Med 1993; 204: 253-60.
17. Lowes K N, Brennan B A, Yeoh G C, Olynyk J K. Oval cells numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154: 537-41.
18. Fujio K, Evarts R P, Hu Z, Marsden E R, Thorgeirsson S S. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in the adult rat. Lab Invest 1994; 704: 511-6.
19. Vandersteenhoven A M, Burchette J, Michalopoulos G K. Characterization of ductular hepatocytes in end-stage cirrhosis. Arch Pathol Lab Med 1990; 114: 403-6.
20. Dabeva M D, Shafritz D A. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the d -galactosamine model of liver regeneration. Am J Pathol 1993; 143: 1606-20.
21. Shinozuka H, Lombardi B, Sell S, Iammario R M. Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet. Cancer Res 1978; 38: 1092-8.
22. Novikoff P, Yam A, Oikawa I. Blast-like cell compartment in carcinogen-induced prolferating bile ductules. Am J Pathol 1996; 148: 1473-92.
23. Tian Y W, Smith P G, Yeoh G C. The oval-shaped cell as a candidate for liver stem cell in embryonic, neonatal and precancerous liver: identification based on morphology and immunohistochemical staining for albumin and pyrouvate kinase isoenzyme expression. Histochem Cell Biol 1997; 107: 243-50.
24. Tee L B, Kirilak Y, Huang W H, Morgan R H, Yeoh G C. Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine. Carcinogenesis 1994; 15: 2747-56.
25. Ray M B, Mendenhall C L, French S W, Gartside P S. Bile duct changes in alcoholic liver disease. The veterans administration cooperative study group. Liver 1993; 13: 36-45.
26. Hsia C C, Evarts R P, Nakatsukasa H, Marsden E R, Thorgeirsson S S. Occurrence of oval type cells in hepatitis B virus associated human hepatocarcinogenesis. Hepatology 1992; 16: 1327-33.
27. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic 'progenitor cells'correlates with parenchymal inflammation in chronic viral hepatitis: Can 'progenitor cells'migrate? J Pathol 2000; 192: 373-8.
28. Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin Diagn Pathol 1998; 15: 259-69.
29. Ravazoula P, Tsamandas A, Gogos C, et al. The potential role of oval hepatocytes expression in cases of chronic hepatitis B and C and their relation to presence of hepatocellular carcinoma [abstract]. Mod Pathol 2002; 15: 292A.
30. Lee R G. Chronic hepatitis. In: Lee R G, ed. Diagnostic Liver Pathology, 1st edn. Mosby-Year book: St. Louis, 1994; 57-79.
31. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
32. Salakou S, Tsamandas A C, Bonikos D S, Papapetropoulos T, Dougenis D. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters. Eur J Cardiothorac Surg 2001; 20: 712-21.
33. Tsamandas A C, Thomopoulos K, Zolota V, et al. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: A clinicopathologic study. Mod Pathol 2003; 16: 1273-88.
34. Lim R, Knight B, Patel K, McHutchison J G, Yeoh G C, Olynyk J K. Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology 2006; 43: 1074-83.
35. Tee L B, Smith P G, Yeoh G C. Expression of α, μ and pi class glutathione S-transferases in oval and ductal cells in liver of rats placed on a choline-deficient, ethionine-supplemented diet. Carcinogenesis 1992; 13: 1879-85.
36. Brooling J T, Campbell J S, Mitchell C, Yeoh G C, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 2005; 41: 906-15.
37. Yin L, Lynch D, Ilic Z, Sell S. Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CCl4/2-AAF injury. Histol Histopathol 2002; 17: 65-81.
38. Clouston A D, Powell E E, Walsh M J, Richardson M M, Demetris A J, Jonsson J R. Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis. Hepatology 2005; 41: 809-18.
39. Theise N D, Saxena R, Portmann B C, et al. The canals of hering and hepatic stem cells in humans. Hepatology 1999; 30: 1425-33.